Examining how the COVID-19 pandemic has affected Hispanic infant health outcomes.
The Impact of the COVID19 Pandemic on the Hispanic/Latinx Birth Outcome Advantage
This study looks at how the COVID-19 pandemic has affected the health of Hispanic infants, who usually have better birth outcomes, to see if this trend has changed and to find out where support is needed most.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-10790872 on NIH RePORTER |
What this research studies
This research investigates the impact of the COVID-19 pandemic on the health outcomes of Hispanic infants, a population that has historically shown better birth outcomes compared to other groups. By analyzing U.S. Natality data from 2015 to 2022, the study aims to determine if the pandemic has disrupted this advantage, focusing on factors such as nativity, region of origin, and maternal education. The research will also explore variations in impacts based on county-level disease burden and socioeconomic factors, providing insights into where resources may be needed most. This approach will help identify specific contexts and populations that may require targeted support.
Who could benefit from this research
Good fit: Ideal candidates for this research include Hispanic families with infants or expecting mothers who may have been affected by the COVID-19 pandemic.
Not a fit: Patients who are not part of the Hispanic community or those without infants may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health interventions and resource allocation for Hispanic families during and after the pandemic.
How similar studies have performed: Other research has shown that public health crises can significantly impact specific demographic groups, suggesting that this investigation could yield important findings.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Frank, Reanne — Ohio State University
- Study coordinator: Frank, Reanne
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.